Expert Rev Anticancer Ther. 2009 Aug;9(8):1115-23.

Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.

Lönneborg A, Aarøe J, Dumeaux V, Børresen-Dale AL.

Source

DiaGenic ASA, Oslo, Norway. anders.lonneborg@diagenic.com

Abstract

Early detection of a growing breast tumor is of key importance for patient survival. Despite limitations, mammography screening has improved the detection of breast tumors, however many tumors are not detected. This is especially true for younger women and women with high breast density. Novel diagnostic blood biomarkers either generated by the tumor and released into the blood, or generated by nontumor cells as a response to the tumor presence, can now potentially help improve the accuracy of early-stage breast cancer detection. They include multicomponent biomarkers, circulating tumor cells and RNA expression of peripheral blood. These novel biomarkers and their potential use will be presented and discussed in this review, with special emphasis on gene expression-based markers.

PMID:: 19671031; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Review

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Breast Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Review A role for biomarkers in the screening and diagnosis of breast cancer in younger women. [Expert Rev Mol Diagn. 2007]
Review A role for biomarkers in the screening and diagnosis of breast cancer in younger women.
Esserman LJ, Shieh Y, Park JW, Ozanne EM. Expert Rev Mol Diagn. 2007 Sep; 7(5):533-44.
Review Early detection of breast cancer: new biomarker tests on the horizon? [Mol Diagn Ther. 2009]
Review Early detection of breast cancer: new biomarker tests on the horizon?
Jotwani AC, Gralow JR. Mol Diagn Ther. 2009 Dec 1; 13(6):349-57.
Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer. [PLoS One. 2008]
Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y, Pospisil P, Iyer LK, Adelstein SJ, Kassis AI. PLoS One. 2008; 3(11):e3661. Epub 2008 Nov 6.
Review Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer. [Breast Cancer Res Treat. 2010]
Review Relevance of circulating tumor cells, extracellular nucleic acids, and exosomes in breast cancer.
Friel AM, Corcoran C, Crown J, O'Driscoll L. Breast Cancer Res Treat. 2010 Oct; 123(3):613-25. Epub 2010 Jun 15.
Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis. [Methods Enzymol. 2007]
Liquid chromatography mass spectrometry for quantifying plasma lysophospholipids: potential biomarkers for cancer diagnosis.
Murph M, Tanaka T, Pang J, Felix E, Liu S, Trost R, Godwin AK, Newman R, Mills G. Methods Enzymol. 2007; 433:1-25.

See reviews... See all...

Cited by 2 PubMed Central articles

Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. [PLoS One. 2010]
Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.
Zhang L, Xiao H, Karlan S, Zhou H, Gross J, Elashoff D, Akin D, Yan X, Chia D, Karlan B, et al. PLoS One. 2010 Dec 31; 5(12):e15573. Epub 2010 Dec 31.
Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old. [Mol Cancer. 2010]
Integrative and comparative genomics analysis of early hepatocellular carcinoma differentiated from liver regeneration in young and old.
Colak D, Chishti MA, Al-Bakheet AB, Al-Qahtani A, Shoukri MM, Goyns MH, Ozand PT, Quackenbush J, Park BH, Kaya N. Mol Cancer. 2010 Jun 12; 9:146. Epub 2010 Jun 12.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Found in transcription: gene expression and other novel blood biomarkers for the...
Found in transcription: gene expression and other novel blood biomarkers for the early detection of breast cancer.
Expert Rev Anticancer Ther. 2009 Aug ;9(8):1115-23.

PubMed
Expanding role of bisphosphonates in the management of early breast cancer.
Expanding role of bisphosphonates in the management of early breast cancer.
Expert Rev Anticancer Ther. 2009 Aug ;9(8):1051-4.

PubMed
How should we support pharmaceutical innovation?
How should we support pharmaceutical innovation?
Expert Rev Pharmacoecon Outcomes Res. 2009 Aug ;9(4):313-20.

PubMed
Guided care and the cost of complex healthcare: a preliminary report.
Guided care and the cost of complex healthcare: a preliminary report.
Am J Manag Care. 2009 Aug ;15(8):555-9.

PubMed
Low-energy femoral fractures associated with the long-term use of bisphosphonate...
Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.
Drug Saf. 2009 ;32(9):775-85. doi: 10.2165/00002018-200932090-00002.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: